Apelin effects on blood pressure and RAS in DOCA-salt-induced hypertensive rats

Clinical and Experimental Hypertension

Volumn 35, Issue 7, 2013, Pages 550-557

  Akcilar, Raziye ^a   Turgut, Sebahat ^b   Caner, Vildan ^b   Akcilar, Aydin ^c   Ayada, Ceylan ^a   Elmas, Levent ^b   Özcan, T Olgun ^b  

^a DUMLUPINAR UNIVERSITY   (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

^c Agriculture and Livestock   (Turkey)

Author keywords

Apelin; Apelin receptor (APJ); Blood pressure; Deoxycorticosterone acetate (DOCA); Deoxycorticosterone acetate salt hypertension

Indexed keywords

ANGIOTENSIN II; ANGIOTENSINOGEN; APELIN; APELIN RECEPTOR; DEOXYCORTICOSTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; MESSENGER RNA; PYROGLUTAMYLATED APELIN 13; RECOMBINANT PROTEIN; SODIUM CHLORIDE; TAP WATER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; AORTA TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CONTROLLED STUDY; DRINKING; DRUG EFFICACY; HEART; HYPERTENSION; MALE; NONHUMAN; PLASMA; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; AORTA; BLOOD PRESSURE; DESOXYCORTICOSTERONE ACETATE; ENDOTHELIN-1; HYPERTENSION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MYOCARDIUM; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER;

EID: 84885194314     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2013.764889     Document Type: Article

References (35)

1. Badyal DK, Lata H, Dadhich AP. Animal models of hypertension and effect of drugs. Indian J Pharmacol 2003; 35:349-362
2. Lerman LO, Chade AR, Sica V, Napoli C. Animal models of hypertension: an overview. J Lab Clin Med 2005; 146:160-173
3. Guyton AC, Coleman TG, Cowley AW, Scheel KW, Manning RD, Norman RA. Arterial pressure regulation: overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 1972; 52:584-594
4. Haack D, Möhring J, Möhring B, Petri M, Hackenthal E. Comparative study on development of corticosterone and DOCA hypertension in rats. Am J Physiol Renal Physiol 1977; 233:F403-F411
5. Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998; 251:471-476
6. Lee DK, Cheng R, Nguyen T, et al. Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000; 74:34-41
7. O?Dowd BF, Heiber M, Chan A, et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993; 136:355-360
8. Tatemoto K, Takayama K, Zou MX, et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001; 99:87-92
9. Charles CJ. Putative role for apelin in pressure/volume homeostasis and cardiovascular disease. Cardiovasc Hematol Agents Med Chem 2007; 5:1-10
10. Ishida J, Hashimoto T, Hashimoto Y, et al. Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem 2004; 279:26274-26279.
11. Lee DK, Saldivia VR, Nguyen T, Chen R, George SR, O?Dowd BF. Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology 2005; 146:231-236
12. Bhatia J, Tabassum F, Sharma AK, et al. Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress. Cardiovasc Toxicol 2011; 11:272-279
13. Falcao-Pires I, Goncalves N, Henriques-Coelho T, Moreira-Goncalves D, Roncon Albuquerque R, Leite-Moreira AF. Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 2009; 296:2007-2014
14. Erken HA, Erken G, Genç O. Blood pressure measurement in freely moving rats by the tail cuff method. Clin Exp Hypertens 2013; 35:11-15
15. Larouche I, Schiffrin EL. Cardiac mikrovasculature in DOCAsalt hypertensive rats effect of endothelin ETA receptor antagonism. Hypertension 1999; 34:795-801
16. Veeramani C, Al-Numair KS, Chandramohan G, Alsaif MA, Pugalendi KV. Protective effect of Melothria maderaspatana leaf fraction on electrolytes, catecholamines, endothelial nitric oxide synthase and endothelin-1 peptide in uninephrectomized deoxycorticosterone acetate-salt hypertensive rats. J Nat Med 2011; 10 (1007):11418-011-0621
17. Raij L. Hypertension and Cardiovascular risk factors: role of the angiotensin II-nitric oxide interaction. Hypertension 2001; 37:767-773
18. Day R, Lariviere R, Schiffrin EL. In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens 1995; 8:294-300
19. Hong HJ, Chan P, Liu JC, et al. Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells. Cardiovasc Res 2004; 61:159-168
20. Rakugi H, Tabuchi Y, Nakamaiu M, et al. Endothelin activates the vascular renin angiotensin system in rat mesenteric arteries. Biochem Int 1990; 21:867-872
21. Rossi GP, Colonna S, Pavan E. Endothelin-1 and its mRNA in the wall layers of human arteries at vivo. Circulation 1999; 99:1147-1155
22. Schiffrin EL. Role of Endothelin-1 in hypertension and vascular disease. Am J Hypertens 2001; 14:83-89
23. Seo B, Oemar BS, Siebenmann R, Von Segersen L, Luscher TF. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994; 89:1203-1208
24. Haynes WG, Strachan FE, Webb DJ. Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 1995; 92:357-363
25. Lee DK, Saldivia VR, Nguyen T, et al. Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology 2005; 146:231-236
26. Andersen CU, Markvardsen LH, Hilberg O, Simonsen U. Pulmonary apelin levels and effects in rats with hypoxic pulmonary hypertension. Respir Med 2009; 103:1663-1671
27. Iwanaga Y, Kihara Y, Takenaka H, Kita T. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system. J Mol Cell Cardiol 2006; 41:798-806
28. Zhong JC, Huang DY, Liu GF, et al. Effects of all-trans retinoic acid on orphan receptor APJ signaling in spontaneously hypertensive rats. Cardiovasc Res 2005; 65:743-750
29. Crackower M, Sarao R, Oudit G, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002; 417:822-828
30. Vickers C, Hales P, Kaushik V, et al. Hydrolysis of biological peptides by human angiotensin-converting enzymerelated carboxypeptidase. J Biol Chem 2002; 277:14838-14843
31. Gómez-Guzmán M, Jiménez R, Zarzuelo SM. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension. Free Radic Biol Med 2012; 52:70-79
32. Sunter D, Hewson AK, Dickson SL. Intracerebroventricular injection of apelin-13 reduces food intake in the rat. Neurosci Lett 2003; 353:1-4
33. O?Shea M, Hansen MJ, Tatemoto K, Morris MJ. Inhibitory effect of apelin-12 on nocturnal food intake in the rat. Nutr Neurosci 2003; 6:163-167
34. Valle A, Hoggard N, Adams AC, Roca P, Speakman JR. Chronic central administration of apelin-13 over 10 days increases food intake, body weight, locomotor activity and body temperature in C57BL/6 mice. J Neuroendocrinol 2008; 20:79-84
35. Higuchi K, Masaki T, Gotoh K, et al. An APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology 2007; 148:2690-2697